This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

As Sanofi moves forward with talks to potentially sell a 50% stake its consumer health unit Opella, fears of job cuts and drug shortages have prompted a call for industrial action in the company ...

Sanofi Consumer Healthcare India Limited was incorporated on May 10 2023 pursuant to a Certificate of Incorporation issued by the Registrar of Companies Central Registration Centre. Pursuant to the ...

Paul Hudson is reshaping Sanofi into a modern healthcare company with the ambition to transform the practice of medicine. Paul and the Sanofi teams are focusing efforts to discover, develop, ...

Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis.

Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 15,925.91 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...

The French government is looking at options including taking a public stake in the consumer health business that Sanofi is in talks to sell to US buyout firm Clayton Dubilier & Rice to protect ...

There’s still two weekends left to celebrate Oktoberfest, if you can snag a day-of ticket.

For decades, North Korea has been a pariah state mainly known for its small but significant nuclear capability. But as the axis of aggressors grows closer, Pyongyang is becoming a greater threat to ...